Company / Shareholders' Equity
ImageneBio, Inc. Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$160.6M
FY2025
5-year range
-$160.6M / $207.9M
FY2021-FY2025
Trend
-194.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
ImageneBio, Inc. reports negative total equity of -$161M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$161M in FY2025.
Declined from $147M to -$161M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 194.6% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$160.6M | -194.6% |
| FY2024 | $169.8M | +15.5% |
| FY2023 | $147.0M | -29.3% |
| FY2022 | $207.9M | +305.7% |
| FY2021 | -$101.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026